(Z)-5-(4-((1-(4-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)thiazolidine-2,4-dione

ID: ALA4472170

PubChem CID: 155535482

Max Phase: Preclinical

Molecular Formula: C20H16N4O4S

Molecular Weight: 408.44

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-n2cc(COc3ccc(/C=C4\SC(=O)NC4=O)cc3)nn2)cc1

Standard InChI:  InChI=1S/C20H16N4O4S/c1-27-16-8-4-15(5-9-16)24-11-14(22-23-24)12-28-17-6-2-13(3-7-17)10-18-19(25)21-20(26)29-18/h2-11H,12H2,1H3,(H,21,25,26)/b18-10-

Standard InChI Key:  QREHBNWFOKFYBG-ZDLGFXPLSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   35.6607  -28.0765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2537  -27.3680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4373  -27.3676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0278  -28.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4408  -28.7859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2559  -28.7828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4043  -24.3675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4002  -25.1847    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   42.1761  -25.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6598  -24.7825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.1828  -24.1190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5758  -24.3754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5746  -25.1949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2827  -25.6039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9923  -25.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9895  -24.3718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2809  -23.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6957  -23.9605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4247  -26.2197    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.4392  -23.3431    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.8666  -25.6029    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.1592  -25.1938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4434  -26.4184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4551  -25.6014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6817  -25.3378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1919  -25.9919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6624  -26.6604    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0347  -29.4951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.2175  -29.4979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18  7  2  0
  9 19  2  0
 11 20  2  0
 13 21  1  0
 21 22  1  0
 22 24  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 23  1  0
 27  2  1  0
  5 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4472170

    ---

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pparg Peroxisome proliferator-activated receptor gamma (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.44Molecular Weight (Monoisotopic): 408.0892AlogP: 3.18#Rotatable Bonds: 6
Polar Surface Area: 95.34Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 6.20CX Basic pKa: CX LogP: 3.05CX LogD: 1.89
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.63Np Likeness Score: -1.70

References

1. Elzahhar PA, Alaaeddine R, Ibrahim TM, Nassra R, Ismail A, Chua BSK, Frkic RL, Bruning JB, Wallner N, Knape T, von Knethen A, Labib H, El-Yazbi AF, Belal ASF..  (2019)  Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.,  167  [PMID:30818268] [10.1016/j.ejmech.2019.02.034]

Source